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Among the main intimidation to the sheep and goat population, PPR outbreaks are causing huge losses especially
in endemic areas. During recent times, six outbreaks of PPR were confirmed at semi-organized goat farms/herds
in various regions of Punjab province and Islamabad capital territory (ICT), Pakistan. The disease started after
introduction of new animals at these farms with no history of previous PPR vaccination. The clinical signs appeared
affecting respiratory and enteric systems and spread quickly. Disease caused mortality of 10-20% and morbidity
of 20-40% within a time period of four weeks. Morbidity and mortality rates were 30.38% (86/283) and 15.55%
(44/283), respectively. Three treatment regimes were executed to demonstrate the role of vaccination during
outbreak at these farms. First was to use only the broad spectrum antibiotics (Penicillin & Streptomycin and/ or
Trimethoprim and Sulfadiazine) at two farms (Texilla and Attock). Second treatment regime was to use the same
broad spectrum antibiotic along with extensive fluid therapy (Farms at ICT-1 and ICT-2). The third regime was to
use of broad spectrum antibiotic plus fluid therapy along with vaccinating the herd against PPR during first week
of outbreak (ICT-3 and ICT-4). The third scheme of treatment gave the better results as there was no mortality in
third week post-outbreak. Therefore, it is suggested to give proper importance to PPR vaccination along with
conventional symptomatic treatment when dealing the PPR outbreaks in endemic disease conditions.
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Pakistan at present is having more than 60 million head
of goats, which consist of about 37 well- recognized
breeds found in different regions of the country. Goats
are important animals for humans for providing food in
terms of milk and meat. They play main role in support-
ing millions of people who are poor and living in the
rural areas. The main stock occurs in the form of no-
madic and transhumant production system but the goat
farming for commercial meat production is growing as a
successful business.
PPR has caused significant economic loss in many
parts of Africa and Asia that contain high densities of
small ruminant population. The disease is characterized
by sever pyrexia, anorexia, ulcerative necrotic stomatitis,
diarrhea due to purulent oculo-nasal discharge and* Correspondence: mabnvl@gmail.com
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unless otherwise stated.respiratory distress [1] which may be associated with
coughing, foul offensive breath, pneumonia and death.
Due to respiratory signs, the disease can be confused
with contagious caprine pleuropneumonia (CCPP) and
pasteurellosis. The disease was first time reported in
Pakistan in 1991 [2].
Goats are the main victims of this disease but also in-
volve sheep. The transmission of virus requires close
contact between susceptible and infected animals in the
febrile stage. The discharge from eyes, nose, mouth and
the loose feces contain large amount of virus. Fine in-
fected droplets are released into the air from these secre-
tions and excretions particularly when infected animals
cough and sneeze [3].
In Pakistan, during the last few years, PPR outbreaks
have increased to an alarming level involving newer
areas [4]. Keeping in view all the discussion, this report
is designed to highlight the importance of various treat-
ment strategies including vaccination while combatingral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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out the possibilities to save goat farming from this risk.
Methods
Outbreaks description
Outbreaks were investigated at six semi-organized com-
mercial farms of goats in Islamabad Capital Territory
(ICT) and two nearby areas of Punjab province (Attock,
Taxilla) (Figure 1). The map of area is showing that the
outbreaks occurred in close proximity. All the farms
were having similar housing conditions with no history
of previous PPR vaccination. The disease started after
introduction of new animals to these farms. The animals
(6-10 months of age) were purchased from different live-
stock markets with no history of PPRV vaccination.
Study plan for treatment regimes
The study was planned to demonstrate the affects of
various treatment strategies especially role of vaccination
in the natural outbreak situations. There was three treat-
ment regimes were selected and executed with each
treatment regime was carried out at two farms.
First scheme was to use only broad spectrum antibiotics
(Penicillin-Streptomycin and/or trimethoprim and sulfa-
diazine) at two farms (Texilla and Attock). The antibiotics
were given intramuscularly daily at recommended dose.Figure 1 Locations of farms/herds where PPR outbreaks were investigSecond treatment regime was to use the broad
spectrum antibiotic along with extensive fluid therapy
(Oral and intravenous) at two farms (ICT-1 and
ICT-2). Some salt and sugar preparation (ORS) were
added in drinking water while Ringer-lactate was given
intravenously.
The third regime was to use of broad spectrum anti-
biotic plus fluid therapy as in second group along with
vaccinating the herd against PPR (PestivecR; Jordon)
during first week of outbreak (ICT-3 and ICT-4). The
vaccine was administered subcutaneously at dose rate
of 1ml in adults and 0.5ml in young. Each treatment
was started as soon as the disease was recognized at
the farm.Collection of samples and laboratory confirmation
Nasal and ocular swabs were taken from sick animals
while tissues from lungs, liver, spleen, intestines and
lymph-nodes were collected from dead animals. Blood
serum was also collected from sick animals.
Thirty swabs and sixty serum samples, collected
from clinically suspected animals, were tested for
PPRV confirmation by using Immuno-capture enzyme
linked immune-sorbant assay (IcELISA) and Competi-
tive ELISA (cELISA), respectively.ated.
Table 1 Farm-wise distribution of PPR outbreaks with specie and mortality rate
Area/Farm Animal species Total animal kept Diseased Mortality Morbidity rate % Mortality rate %
Taxilla Goat 55 17 10 30.91 18.18
Fateh-Jung (Attock) Goat 67 16 09 23.88 13.43
*ICT-1 Goat 34 11 04 32.35 11.76
ICT-2 Goat 42 16 07 38.09 16.67
ICT-3 Goat 57 15 09 26.32 13.43
ICT-4 Goat 28 11 05 39.28 17.86
283 86 44 30.38 15.55
*Islamabad Capital Territory.
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fected herds (4 from each herd) were also taken and
tested through Ic ELISA and RT-PCR. In group-wise
comparison, five swabs and ten serum samples were col-
lected in each herd while all morbid animals were sam-
pled for the confirmation of disease.Tests used for the confirmation of outbreaks
PPR antigen detection was performed using (Ic-ELISA)
kit imported from World Reference Laboratory (Pirb-
right, UK). As recommended by the kit manufacturer,
the final absorbance was measured at a wavelength of
492 nm [5].
The presence of viral nucleic acid from tissue samples
was confirmed by Reverse Transcription-Polymerase
Chain Reaction (RT-PCR). Total cellular RNA was ex-
tracted using the Qiagen-RNAeasy kit as per the manu-
facturer’s instructions. RT-PCR was performed for the
F-gene of PPRV using one step RT-PCR kit (Invitrogen)
as per the manufacturer’s instructions. PCR was carried
out using PCR primers and conditions as described pre-
viously [6,7].
PPR antibodies were detected using cELISA kit (col-
lectively produced by Biological Diagnostic Supplies Ltd,
Flow Laboratories and The Pirbright Institute (formerly
Institute for Animal Health). The OD values were con-
verted to percentage inhibition and the samples with PI
>50% were considered as positive [8].Results
Disease started with sudden onset of fever, respiratory
and enteric clinical signs and spread quickly. At threeTable 2 Summary of samples tested with different tests




Swab (ocular and nasal) 30 –
Serum 60 52
Tissue (Lung, Spleen and Lymph-nodes) 24 –farms, 86 out of 283 animals exhibited the clinical
disease, giving morbidity rate of 30.38%. A total of 44
animals died with mortality rate of 15.55% (44/283)
(Table 1).
Among the samples tested, swab and tissue samples
were positive with both Ic-ELISA and RT-PCR while all
the serum samples were found positive for PPR anti-
bodies (Table 2).
There was a variation of mortality pattern in groups
under different treatment regimes. In group I, the mor-
tality continued up-to fourth week of clinical outbreak
while the clinical disease sustained up to sixth week of
its onset. In group II, the mortality stopped in third
week and still the clinical disease continued up to fourth
week post clinical disease.
In group-III, the mortality stopped in second week
while the clinical disease continued up to fourth week
but its symptoms were mild (Table 3). Mortality rate
on first week of the outbreak was similarly high in all
groups but it dropped appreciably in second week in
group 2 and 3. It further dropped in group- 2 in third
week but there was no mortality in group 3 while the
mortality continued in group-1 till fourth week.Discussion
The study presents an important scenario for PPR dis-
ease and its treatment in endemic disease situation in
Pakistan. Due to lack of awareness of disease and no
organized vaccination program, the disease has be-
come endemic in Pakistan [9-11]. In the past PPR out-
breaks were diagnosed only on the basis of clinical
signs because of laborious laboratory procedures, cost& Samples Positive
IcELISA RT-PCR Results
21 25 Positive for PPR antigen + F-gene detection
– – Positive for PPR antibodies
19 22 Positive for PPR antigen + F-gene detection













Taxilla 10 4 3 2 1
Group-1 Fateh-Jung
(Attock)
09 5 2 1 1
Group-2 ICT-1 04 2 1 1 0
ICT-2 07 4 2 1 0
Group-3 ICT-3 09 6 3 0 0
ICT-4 05 4 1 0 0
44 25 12 5 2
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larger population along with the constraint of test
availability. In the present study competitive ELISA
was used with high specificity (99.8%) and sensitivity
(90.5%) for the detection of PPR virus antibodies in
serum samples compared with gold standards like
virus neutralization test VNT [12-14]. The imple-
mentation of cELISA aided in tracking the outbreaks
of PPR disease in different geographical regions,
measuring economic losses from the disease, epi-
demiology of the disease in different population of
animals [1,15].
The mortality in PPR goats can be up to 100% in se-
vere infections, but during milder outbreaks less than
50% mortality may be seen [16]. However, published
information on the survivability of goats diagnosed
with clinical PPR, under different antimicrobial ther-
apies are sparse, if not absent. The results of the
present study revealed that survivability in different
treatment groups varies (Table 3). These treatment
strategies are usually applied to combat PPR outbreaks
in the field. Narayanan et al. [17] treated clinical cases
of PPR were treated with broad-spectrum antibiotics
like enrofloxcin, @5mg per kg body weight. Intestinal
astringents like creta and kaolin were administered.
Intravenous fluids like dextrose normal saline (10ml/
kg body weight), was administered for the treatment
of diarrhea and restoration of body fluid ionic balance
for seven days as described by Wosu [18] and
Abubakar and Irfan [19]. In contrast, we used above
strategies along with use of PPR vaccine which proved
the best in combating the outbreaks.
Virus induced immune-suppression attributable to
leucopenia predisposes secondary bacterial infections,
where bronchopneumonia is the most frequently
observed bacterial complication in peste des petits
ruminants virus (PPRV)-infected animals [16,20,21].
Common secondary infections include Pasteurella
species [21]. The disease is highly endemic in South
Asia, caused by lineage 4 of PPRV unlike Sub-Saharancountries where circulation of lineages 1-3 are re-
ported [2]. Because the outcome of PPRV infections
can be linked to secondary bacterial infections, it is
important to treat them appropriately, subsequently
an increased survivability might be achieved.
A possible explanation for outbreaks could be the
excretion of PPR viral antigen in some body secretion.
Abubakar et al. [22] explained the possible excretion
of PPRV antigen in fecal material in which they de-
scribed a possible mechanism of virus transmission
following natural infection. This idea may demonstrate
a potential method by which PPRV outbreaks occur
spontaneously in areas not previously known to have
circulating virus. Shedding of PPRV antigen in the
fecal material of the recovered goats following a dis-
ease incursion put forward the possibility that goats
may be shedding the PPR virus in their fecal matter.
These findings are also in agreement with Ezeibe et al.
[23] and may reinforce the idea that virus can sub-
clinically infect animals and excrete and/or transmit
virus to naïve ‘in contact’ animals.Conclusion
The main reason for these outbreaks could be the en-
demic nature of PPR disease in Pakistan and as there is
no organized program for its vaccination. Therefore, it is
recommended that proper importance should be given
to treatment regimes as mentioned above as well as vac-
cination during the face of a PPR outbreak.
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